These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 22244515)
1. Serum brain-derived neurotrophic factor level in relation to illness severity and episode duration in patients with major depression. Birkenhäger TK; Geldermans S; Van den Broek WW; van Beveren N; Fekkes D J Psychiatr Res; 2012 Mar; 46(3):285-9. PubMed ID: 22244515 [TBL] [Abstract][Full Text] [Related]
2. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Aydemir O; Deveci A; Taneli F Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):261-5. PubMed ID: 15694233 [TBL] [Abstract][Full Text] [Related]
3. Duration of last depressive episode may influence serum BDNF levels in remitted patients with major depression. Takebayashi N; Maeshima H; Baba H; Nakano Y; Satomura E; Kita Y; Namekawa Y; Nomoto H; Suzuki T; Arai H Depress Anxiety; 2012 Sep; 29(9):775-9. PubMed ID: 22447660 [TBL] [Abstract][Full Text] [Related]
4. Elevated Brain-Derived Neurotrophic Factor Correlates Negatively with Severity and Duration of Major Depressive Episodes. Kheirouri S; Noorazar SG; Alizadeh M; Dana-Alamdari L Cogn Behav Neurol; 2016 Mar; 29(1):24-31. PubMed ID: 27008247 [TBL] [Abstract][Full Text] [Related]
5. Lower levels of brain-derived neurotrophic factor are associated with melancholic psychomotor retardation among depressed inpatients. Primo de Carvalho Alves L; Sica da Rocha N Bipolar Disord; 2018 Dec; 20(8):746-752. PubMed ID: 29516593 [TBL] [Abstract][Full Text] [Related]
6. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine. Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053 [TBL] [Abstract][Full Text] [Related]
7. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Gervasoni N; Aubry JM; Bondolfi G; Osiek C; Schwald M; Bertschy G; Karege F Neuropsychobiology; 2005; 51(4):234-8. PubMed ID: 15897674 [TBL] [Abstract][Full Text] [Related]
8. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076 [TBL] [Abstract][Full Text] [Related]
9. Illness severity and biomarkers in depression: Using a unidimensional rating scale to examine BDNF. Caldieraro MA; Vares EA; Souza LH; Spanemberg L; Guerra TA; Wollenhaupt-Aguiar B; Ferrari P; Nierenberg AA; Fleck MP Compr Psychiatry; 2017 May; 75():46-52. PubMed ID: 28301802 [TBL] [Abstract][Full Text] [Related]
10. Serum Brain-derived neurotrophic factor (BDNF): the severity and symptomatic dimensions of depression. Jevtović S; Karlović D; Mihaljević-Peleš A; Šerić V; Vrkić N; Jakšić N Psychiatr Danub; 2011 Dec; 23(4):363-9. PubMed ID: 22075737 [TBL] [Abstract][Full Text] [Related]
11. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Karege F; Perret G; Bondolfi G; Schwald M; Bertschy G; Aubry JM Psychiatry Res; 2002 Mar; 109(2):143-8. PubMed ID: 11927139 [TBL] [Abstract][Full Text] [Related]
12. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Jindal RD; Pillai AK; Mahadik SP; Eklund K; Montrose DM; Keshavan MS Schizophr Res; 2010 Jun; 119(1-3):47-51. PubMed ID: 20096541 [TBL] [Abstract][Full Text] [Related]